The estimated Net Worth of Oene Mark Van is at least $216 Million dollars as of 16 August 2024. Mr. Van owns over 38,011 units of Illumina Inc stock worth over $203,574,636 and over the last 7 years he sold ILMN stock worth over $9,730,009. In addition, he makes $3,106,860 as Senior Vice President and Chief Commercial Officer at Illumina Inc.
Mark has made over 28 trades of the Illumina Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 38,011 units of ILMN stock worth $63,098 on 16 August 2024.
The largest trade he's ever made was selling 41,480 units of Illumina Inc stock on 11 January 2022 worth over $590,260. On average, Mark trades about 6,520 units every 63 days since 2017. As of 16 August 2024 he still owns at least 1,630,815 units of Illumina Inc stock.
You can see the complete history of Mr. Van stock trades at the bottom of the page.
Mark Van Oene is the Senior Vice President, Chief Commercial Officer of Illumina, Inc. Mr. Van Oenewas previously the Company's Senior Vice President of the Americas region and subsequently named interim Chief Commercial Officer in late 2016. He will be responsible for worldwide sales, services, and marketing at the Company.
As the Senior Vice President and Chief Commercial Officer of Illumina Inc, the total compensation of Mark Oene at Illumina Inc is $3,106,860. There are 1 executives at Illumina Inc getting paid more, with Mostafa Ronaghi having the highest compensation of $3,541,310.
Mark Oene is 46, he's been the Senior Vice President and Chief Commercial Officer of Illumina Inc since 2017. There are 20 older and 1 younger executives at Illumina Inc. The oldest executive at Illumina Inc is John Thompson, 71, who is the Lead Independent Director.
Oene's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,, 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025.
Over the last 21 years, insiders at Illumina Inc have traded over $412,190,379 worth of Illumina Inc stock and bought 13,386 units worth $1,243,499 . The most active insiders traders include John Wendell Thompson, Jay T Flatley, and Robert Nelsen. On average, Illumina Inc executives and independent directors trade stock every 5 days with the average trade being worth of $954,700. The most recent stock trade was executed by Jacob Thaysen on 22 February 2024, trading 7,330 units of ILMN stock currently worth $991,676.
at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina Inc executives and other stock owners filed with the SEC include: